Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome
KIDNEY INTERNATIONAL REPORTS（2023）
Key words
aHUS,alternative pathway,atypical hemolytic uremic syndrome,Factor B,iptacopan,LNP023
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined